1. The role of neuroleptics in tardive dyskinesia

   Newsletter Article 17 February 2013 Pages: 2 - 2

2. Renal complications of gold therapy

   Newsletter Article 17 February 2013 Pages: 2 - 3

3. Interferon-induced CNS toxicity

   Newsletter Article 17 February 2013 Pages: 3 - 3

4. Alteplase

   Newsletter Article 17 February 2013 Pages: 4 - 4

5. Amiodarone

   Newsletter Article 17 February 2013 Pages: 4 - 4

6. Antineoplastics

   Newsletter Article 17 February 2013 Pages: 4 - 4

7. Atenolol + chlorthalidone

   Newsletter Article 17 February 2013 Pages: 4 - 4

8. Camylofin overdose

   Newsletter Article 17 February 2013 Pages: 4 - 5

9. Carbamazepine withdrawal

   Newsletter Article 17 February 2013 Pages: 5 - 5

10. Chlorthalidone see Atenolol + chlorthalidone

    Newsletter Article 17 February 2013 Pages: 5 - 5

11. Cibenzoline

    Newsletter Article 17 February 2013 Pages: 5 - 5

12. Cilazapril

    Newsletter Article 17 February 2013 Pages: 5 - 5

13. Cinnarizine/flunarizine

    Newsletter Article 17 February 2013 Pages: 5 - 5

14. Cinoxacin

    Newsletter Article 17 February 2013 Pages: 5 - 5

15. Ciprofloxacin see Theophylline interaction

    Newsletter Article 17 February 2013 Pages: 5 - 5

16. Cocaine abuse

    Newsletter Article 17 February 2013 Pages: 5 - 6

17. Cloxacillin

    Newsletter Article 17 February 2013 Pages: 6 - 6

18. Cotrimoxazole

    Newsletter Article 17 February 2013 Pages: 6 - 6

19. Digoxin overdose

    Newsletter Article 17 February 2013 Pages: 6 - 6

20. Doxycycline

    Newsletter Article 17 February 2013 Pages: 6 - 6

21. Erythromycin see Lovastatin interaction

    Newsletter Article 17 February 2013 Pages: 6 - 6

22. Etretinate

    Newsletter Article 17 February 2013 Pages: 6 - 6

23. Flunarizine see Cinnarizine/flunarizine

    Newsletter Article 17 February 2013 Pages: 6 - 6

24. Fluoxetine

    Newsletter Article 17 February 2013 Pages: 6 - 6

25. Furosemide

    Newsletter Article 17 February 2013 Pages: 6 - 6

26. Gemfibrozil

    Newsletter Article 17 February 2013 Pages: 6 - 7

27. Interferon alpha 2

    Newsletter Article 17 February 2013 Pages: 7 - 7

28. Interferon alpha 2B

    Newsletter Article 17 February 2013 Pages: 7 - 7

29. Interferon gamma

    Newsletter Article 17 February 2013 Pages: 7 - 7

30. Isoniazid see Ketoconazole interaction

    Newsletter Article 17 February 2013 Pages: 7 - 7

31. Ketoconazole interaction

    Newsletter Article 17 February 2013 Pages: 7 - 7

32. Lithium interaction

    Newsletter Article 17 February 2013 Pages: 7 - 7

33. Lovastatin interaction

    Newsletter Article 17 February 2013 Pages: 8 - 8

34. Maprotiline

    Newsletter Article 17 February 2013 Pages: 8 - 8

35. Mefenamic acid see Lithium interaction

    Newsletter Article 17 February 2013 Pages: 8 - 8

36. Methotrexate

    Newsletter Article 17 February 2013 Pages: 8 - 8

37. Metoclopramide

    Newsletter Article 17 February 2013 Pages: 8 - 9

38. Metronidazole

    Newsletter Article 17 February 2013 Pages: 9 - 9

39. Ofloxacin interaction

    Newsletter Article 17 February 2013 Pages: 9 - 9

40. Oxymetazoline see Cocaine abuse

    Newsletter Article 17 February 2013 Pages: 9 - 9

41. Penicillins

    Newsletter Article 17 February 2013 Pages: 9 - 9

42. Pentamidine

    Newsletter Article 17 February 2013 Pages: 9 - 9

43. Phenazopyridine

    Newsletter Article 17 February 2013 Pages: 9 - 10

44. Rifampicin see Ketoconazole interaction

    Newsletter Article 17 February 2013 Pages: 10 - 10

45. Sodium aurothiomalate

    Newsletter Article 17 February 2013 Pages: 10 - 10

46. Streptokinase

    Newsletter Article 17 February 2013 Pages: 10 - 10

47. Suramin

    Newsletter Article 17 February 2013 Pages: 10 - 10

48. Theophylline

    Newsletter Article 17 February 2013 Pages: 10 - 12

49. Tranylcypromine see Fluoxetine

    Newsletter Article 17 February 2013 Pages: 12 - 12

50. Tocainide

    Newsletter Article 17 February 2013 Pages: 12 - 12